JPS57134419A - Stable anticoagulant of blood - Google Patents

Stable anticoagulant of blood

Info

Publication number
JPS57134419A
JPS57134419A JP56017994A JP1799481A JPS57134419A JP S57134419 A JPS57134419 A JP S57134419A JP 56017994 A JP56017994 A JP 56017994A JP 1799481 A JP1799481 A JP 1799481A JP S57134419 A JPS57134419 A JP S57134419A
Authority
JP
Japan
Prior art keywords
atiii
heparin
blood
low
affinitive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP56017994A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6353970B2 (enExample
Inventor
Takeshi Suzuki
Yoshitoshi Sano
Tetsuya Tajima
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eisai Co Ltd
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Priority to JP56017994A priority Critical patent/JPS57134419A/ja
Priority to US06/345,834 priority patent/US4415559A/en
Priority to EP82101017A priority patent/EP0058397A3/en
Publication of JPS57134419A publication Critical patent/JPS57134419A/ja
Publication of JPS6353970B2 publication Critical patent/JPS6353970B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
JP56017994A 1981-02-12 1981-02-12 Stable anticoagulant of blood Granted JPS57134419A (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP56017994A JPS57134419A (en) 1981-02-12 1981-02-12 Stable anticoagulant of blood
US06/345,834 US4415559A (en) 1981-02-12 1982-02-04 Anticoagulant
EP82101017A EP0058397A3 (en) 1981-02-12 1982-02-11 Anticoagulant and the use thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP56017994A JPS57134419A (en) 1981-02-12 1981-02-12 Stable anticoagulant of blood

Publications (2)

Publication Number Publication Date
JPS57134419A true JPS57134419A (en) 1982-08-19
JPS6353970B2 JPS6353970B2 (enExample) 1988-10-26

Family

ID=11959270

Family Applications (1)

Application Number Title Priority Date Filing Date
JP56017994A Granted JPS57134419A (en) 1981-02-12 1981-02-12 Stable anticoagulant of blood

Country Status (3)

Country Link
US (1) US4415559A (enExample)
EP (1) EP0058397A3 (enExample)
JP (1) JPS57134419A (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3366933D1 (en) 1982-06-10 1986-11-20 Kabivitrum Ab Antithrombin-heparin complex
US4745106A (en) * 1986-08-20 1988-05-17 Griffin Charles C Heparin derivatives having improved anti-Xa specificity
US4942156A (en) * 1986-08-20 1990-07-17 Hepar Industries, Inc. Low molecular weight heparin derivatives having improved anti-Xa specificity
IT1237518B (it) * 1989-11-24 1993-06-08 Renato Conti Eparine supersolfatate
SE9003181D0 (sv) * 1990-10-04 1990-10-04 Kabivitrum Ab Use of heparin fraction
WO1993006836A1 (en) * 1991-10-04 1993-04-15 Virginia Commonwealth University Von willebrand factor-specific heparin fractions
CA2137258A1 (en) * 1993-04-05 1994-10-13 Yoshitomi Pharmaceutical Industries Ltd. Liquid preparation of antithrombin-iii and stabilizing method therefor
DE19538716A1 (de) * 1995-10-18 1997-04-24 Behringwerke Ag Verfahren zur Quantifizierung von aktiviertem Gerinnungsfaktor VII (FVIIa)
DE19538715A1 (de) 1995-10-18 1997-04-30 Behringwerke Ag Verfahren zur Reinigung von Faktor VII und aktiviertem Faktor VII
WO1999010746A2 (en) * 1997-08-26 1999-03-04 The University Of North Carolina At Chapel Hill Method of monitoring blood low molecular weight heparin and heparin
RU2138269C1 (ru) * 1997-12-04 1999-09-27 Ашмарин Игорь Петрович Антитромботическое средство
US20070166344A1 (en) * 2006-01-18 2007-07-19 Xin Qu Non-leaching surface-active film compositions for microbial adhesion prevention

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4119774A (en) * 1976-03-05 1978-10-10 Ab Kabi Heparin purification method
US4301153A (en) * 1977-03-21 1981-11-17 Riker Laboratories, Inc. Heparin preparation
US4122250A (en) * 1977-08-22 1978-10-24 Gottfried Schmer Separation of high-activity heparin by affinity chromatography
US4175182A (en) * 1978-07-03 1979-11-20 Research Corporation Separation of high-activity heparin by affinity chromatography on supported protamine
FR2461719A2 (fr) * 1979-07-20 1981-02-06 Choay Sa Composition mucopolysaccharidique ayant une activite regulatrice de la coagulation, medicament la contenant et procede pour l'obtenir
GB2051103A (en) * 1979-04-11 1981-01-14 Choay Sa Heparin fractions
IL61201A (en) * 1979-10-05 1984-09-30 Choay Sa Oligosaccharides having no more than 8 saccharide moieties,their obtention from heparin and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
EP0058397A3 (en) 1984-01-04
JPS6353970B2 (enExample) 1988-10-26
US4415559A (en) 1983-11-15
EP0058397A2 (en) 1982-08-25

Similar Documents

Publication Publication Date Title
FI960045A0 (fi) Solujen valmistus ja stabilointi
AU4722785A (en) Initiating reperfusion treatment when heart attack symptoms are present
FI965145A0 (fi) Suodatus
DE68901098D1 (de) Zusammensetzung aus antikoagulantia.
CA2271232A1 (en) Modified protein c and methods of use thereof
JPS57149228A (en) Novel erythropoietin and its preparation
SE8506078L (sv) Sett for stromlos forkoppring och komposition for utforande av settet
JPS56139419A (en) Erythrocytic preservative and erythrocytic pharmaceutical for preservation
CA2060507A1 (en) Factor xa based anticoagulant compositions
Hawkins et al. Studies on cholinesterase. 6. The selective inhibition of true cholinesterase in vivo
EP0340305A4 (en) Hemolysis inhibitor and plasticizer.
WO2001047576A3 (en) Compositions for replacement fluid and associated systems and methods usable in the performance of frequent hemofiltration
GR3034946T3 (en) Preparation of factor ix.
EP0071414A3 (en) Detergent compositions
EP0058397A3 (en) Anticoagulant and the use thereof
Bajwa et al. A new method for purification of the thrombin-like enzyme from the venom of the eastern diamondback rattlesnake
JPS5569595A (en) Novel substance having fibrinolytic activity, remedy for thrombotic embolic disease comprising it, and its preparation
ES8507000A1 (es) Metodo para la preparacion y purificacion de concentrados de factor viii antihemofilia de la sangre
GB2135022B (en) Improvements in or relating to impeller pumps particularly for fire fighting
JPS577419A (en) Erythrocyte storing solution
ES8504210A1 (es) Procedimiento de preparacion de globina a partir de hemoglobina
JPS5762218A (en) Ophthalmic solution
Takenaka et al. Oxygen equilibrium characteristics of adult and fetal hemoglobin of japanese monkey Macaca fuscata
JPS57130545A (en) Urea adsorbing agent
JPS5513002A (en) Preparation of urokinase